Ultime notizie per Mainz Biomed (NASDAQ:MYNZ) Azioni

Mainz Biomed

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

NIO Inc. &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) shares <a href="https://www.benzinga.com/movers" target="_blank" rel="noreferrer noopener">are rising on Friday</a>.
The company&#8217;s family-oriented sub-brand Onvo reportedly kicked off pre-sales for its new flagship SUV, the L90.
The launch positions Nio for a direct face-off with domestic rival Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>), which is preparing to debut its first fully electric SUV, the Li i8, later this month, <a href="https://cnevpost.com/2025/07/11/nio-onvo-begins-pre-sales-l90/" target="_blank" rel="noreferrer noopener">reports </a>CnEV Post.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/asia/25/07/46241878/tesla-rival-xiaomi-wants-to-sell-cars-internationally-starting-2027-ceo-lei-jun-says" rel="noreferrer noopener">Tesla Rival Xiaomi Wants To Sell Cars Internationally Starting 2027, CEO Lei Jun Says</a>
Morgan Stanley analyst Tim Hsiao reiterated his Buy rating on Nio, with a $5.90 price target, citing the launch of the <a href="https://www.benzinga.com/quote/NIO/analyst-ratings" target="_blank" rel="noreferrer noopener">Onvo L90 electric SUV as a key catalyst.</a>
The L90 pre-sales began at a tech event in Hefei, home to Nio&#8217;s production facilities.
Onvo set an initial price of RMB279,900 ($39,000), including an 85-kWh battery — under CEO William Li&#8217;s previously stated RMB300,000 target and potentially even lower at official launch
The L90 is expected to undercut Li Auto&#8217;s upcoming Li i8 and its premium Li L9 model, which starts at RMB409,800, CnEV Post adds.
Onvo&#8217;s SUV will be available in six- and seven-seat variants, with a five-seat L80 version set to launch later this year. The
L90&#8217;s dimensions and conventional SUV styling reflect current Chinese consumer preferences and contrast with Li i8&#8217;s MPV-inspired design.
At the event, Nio&#8217;s CEO highlighted the L90&#8217;s energy efficiency and lightweight construction.
The SUV weighs between 2,250 kg and 2,385 kg, lighter than the Li i8, which ranges from 2,580 kg to 2,610 kg.
Nio also leverages its extensive charging infrastructure — over 3,400 battery swap stations and nearly 2,900 superchargers — to support the L90 rollout.
Showroom vehicles are already available across Onvo&#8217;s retail network, with official deliveries scheduled to begin Aug. 1.
This rapid deployment mirrors Li Auto&#8217;s efficiency in rolling out new models, suggesting NIO is keen on matching its rival&#8217;s speed and execution in the increasingly competitive EV market.
NIO Price Action: Nio shares are trading higher by 5.56% to $3.90 at publication on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46367400/why-ionq-is-my-top-stock-pick-for-2025" target="_blank" rel="noreferrer noopener">Why IonQ Is My Top Stock Pick For 2025</a></li>
</ul>
Photo: Courtesy Nio

Equities

News

Global

Markets

Movers

General

Why NIO Stock Is Gaining Today

JBLU

Shares airline stocks are trading lower amid a rise in oil prices and renewed tariff concerns. The sector may also be pulling back after recently rising on strong earnings from Delta.

<h3>Gainers</h3>
<ul>
<li>LQR House (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YHC#NASDAQ">YHC</a>) stock rose 34.2% to $2.66 during Friday's regular session. The company's market cap stands at $2.1 million. </li>
<li>Urban One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UONEK#NASDAQ">UONEK</a>) stock increased by 12.43% to $0.72. The market value of their outstanding shares is at $29.3 million. </li>
<li>Smart Digital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDM#NASDAQ">SDM</a>) stock moved upwards by 12.01% to $14.26. The market value of their outstanding shares is at $340.2 million. </li>
<li>Sound Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOGP#NASDAQ">SOGP</a>) stock increased by 10.64% to $6.4. The market value of their outstanding shares is at $30.5 million. </li>
<li>AMC Entertainment Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) shares increased by 9.99% to $3.3. The market value of their outstanding shares is at $1.2 billion. </li>
<li>Baosheng Media Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) shares increased by 9.88% to $2.9. The company's market cap stands at $4.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Pop Culture Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) stock declined by 22.8% to $0.69 during Friday's regular session. The market value of their outstanding shares is at $13.4 million. </li>
<li>GIBO Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIBO#NASDAQ">GIBO</a>) stock decreased by 12.27% to $0.04. The market value of their outstanding shares is at $35.4 million. </li>
<li>Mega Matrix (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MPU#AMEX">MPU</a>) shares decreased by 10.8% to $1.9. The market value of their outstanding shares is at $86.6 million. </li>
<li>LZ Technology Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) stock declined by 9.53% to $5.7. The market value of their outstanding shares is at $958.0 million. </li>
<li>E W Scripps (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSP#NASDAQ">SSP</a>) shares declined by 9.52% to $3.75. The market value of their outstanding shares is at $363.3 million. </li>
<li>Super League Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) stock fell 9.21% to $6.02. The market value of their outstanding shares is at $5.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BAOS

CPOP

GIBO

LZMH

Morgan Stanley Capital-Protected Notes Based on Value of S&P 500 Index

SOGP

UONEK

12 Communication Services Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>MiNK Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INKT#NASDAQ">INKT</a>) stock increased by 775.2% to $67.65 during Friday's regular session. The market value of their outstanding shares is at $30.8 million. </li>
<li>Connect Biopharma Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTB#NASDAQ">CNTB</a>) stock rose 25.65% to $1.45. The company's market cap stands at $63.8 million. </li>
<li>CalciMedica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALC#NASDAQ">CALC</a>) stock moved upwards by 23.37% to $2.0. The market value of their outstanding shares is at $22.6 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) stock rose 22.05% to $2.82. The market value of their outstanding shares is at $288.6 million. </li>
<li>Alterity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) shares rose 21.96% to $4.74. The market value of their outstanding shares is at $57.5 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares rose 16.75% to $2.23. The company's market cap stands at $63.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Milestone Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIST#NASDAQ">MIST</a>) shares decreased by 38.9% to $1.56 during Friday's regular session. The company's market cap stands at $136.8 million. </li>
<li>Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) stock fell 31.08% to $7.86. The company's market cap stands at $521.0 million. </li>
<li>HeartSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSCS#NASDAQ">HSCS</a>) shares declined by 30.92% to $3.96. The market value of their outstanding shares is at $6.1 million. </li>
<li>Pelthos Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PTHS#AMEX">PTHS</a>) stock declined by 30.56% to $18.39. The company's market cap stands at $17.1 million. </li>
<li>Basel Medical Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) shares fell 24.25% to $2.25. The company's market cap stands at $55.7 million. </li>
<li>Karyopharm Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPTI#NASDAQ">KPTI</a>) stock declined by 24.2% to $3.79. The market value of their outstanding shares is at $43.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Alterity Therapeutics Limited - American Depositary Shares

ATHE

BMGL

CALC

CAPR

CNTB

HSCS

INKT

JUNS

KPTI

MIST

PTHS

12 Health Care Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) shares moved upwards by 26.8% to $0.06 during Friday's regular session. The market value of their outstanding shares is at $1.4 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) shares rose 26.34% to $0.49. The market value of their outstanding shares is at $6.7 million. </li>
<li>Surf Air Mobility (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) shares rose 24.73% to $9.46. The company's market cap stands at $260.7 million. </li>
<li>AIRO Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRO#NASDAQ">AIRO</a>) stock rose 22.15% to $27.12. The company's market cap stands at $552.8 million. </li>
<li>Safe Pro Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPAI#NASDAQ">SPAI</a>) stock rose 20.58% to $3.45. The company's market cap stands at $43.3 million. </li>
<li>AgEagle Aerial Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#AMEX">UAVS</a>) shares moved upwards by 20.16% to $1.49. The company's market cap stands at $17.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Concorde Intl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIGL#NASDAQ">CIGL</a>) stock decreased by 24.2% to $4.29 during Friday's regular session. The company's market cap stands at $126.3 million. </li>
<li>Nuvve Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVVE#NASDAQ">NVVE</a>) shares decreased by 14.43% to $0.93. The company's market cap stands at $10.3 million. </li>
<li>EuroDry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDRY#NASDAQ">EDRY</a>) shares declined by 11.16% to $8.84. The market value of their outstanding shares is at $28.1 million. </li>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) stock decreased by 10.93% to $5.38. The company's market cap stands at $10.8 million. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) shares decreased by 10.45% to $1.2. The market value of their outstanding shares is at $20.2 million. </li>
<li>Founder Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGL#NASDAQ">FGL</a>) shares fell 9.06% to $0.9. The company's market cap stands at $19.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRO

BGLC

CIGL

EDRY

GPUS

NVVE

SPAI

SRFM

UAVS

WLGS

ZBAI

12 Industrials Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) shares rose 102.4% to $2.49 during Friday's regular session. The company's market cap stands at $4.4 million. </li>
<li>Zepp Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) stock increased by 54.02% to $9.38. The company's market cap stands at $365.2 million. </li>
<li>Bit Origin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) stock increased by 51.34% to $0.44. The market value of their outstanding shares is at $17.1 million. </li>
<li>Unusual Machines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#AMEX">UMAC</a>) stock increased by 43.03% to $12.43. The company's market cap stands at $217.6 million. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) stock moved upwards by 42.05% to $1.52. The company's market cap stands at $19.4 million. </li>
<li>Abits Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) stock moved upwards by 27.4% to $5.7. The company's market cap stands at $10.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BIT Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NYSE">BTCM</a>) stock decreased by 31.2% to $4.3 during Friday's regular session. The market value of their outstanding shares is at $99.7 million. </li>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) shares declined by 20.91% to $2.46. The company's market cap stands at $8.2 million. </li>
<li>3 E Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASK#NASDAQ">MASK</a>) shares fell 17.84% to $1.76. The market value of their outstanding shares is at $26.7 million. </li>
<li>Next Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) stock decreased by 17.24% to $2.4. The market value of their outstanding shares is at $1.2 billion. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) stock decreased by 13.53% to $1.38. The company's market cap stands at $247.4 million. </li>
<li>BitMine Immersion Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) shares fell 12.72% to $40.16. The market value of their outstanding shares is at $2.3 billion. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABTS

BMNR

BTCM

BTOG

MASK

Next Technology Holding Inc. - Ordinary Shares

NXTT

SLNH

UMAC

WOLF

ZEPP

12 Information Technology Stocks Moving In Friday's Intraday Session

Macro Economic Events

Econ #s

Economics

U.S. Baker Hughes Oil Rig Count -1 To 424; U.S. Baker Hughes NatGas Rig Count Unchanged At 108; U.S. Baker Hughes Total Rig Count 537

Analyst Ratings

Trading Ideas

UBER

CNBC Halftime Report Final Trades: Uber Technologies, Zimmer Biomet, Boeing, Delta Air Lines

Whales with a lot of money to spend have taken a noticeably bearish stance on Adobe.
Looking at options history for Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) we detected 44 trades.
If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 13 are puts, for a total amount of $799,828 and 31, calls, for a total amount of $1,489,543.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $220.0 to $520.0 for Adobe during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Adobe options trades today is 579.21 with a total volume of 3,222.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Adobe's big money trades within a strike price range of $220.0 to $520.0 over the last 30 days.
<h3>Adobe Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752253247_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/17/25</td>
<td>$141.9</td>
<td>$139.7</td>
<td>$141.0</td>
<td>$510.00</td>
<td>$211.5K</td>
<td>0</td>
<td align="right">15</td>
</tr>
<tr>
<td>ADBE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$4.0</td>
<td>$3.7</td>
<td>$4.0</td>
<td>$370.00</td>
<td>$100.0K</td>
<td>533</td>
<td align="right">530</td>
</tr>
<tr>
<td>ADBE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$15.9</td>
<td>$15.7</td>
<td>$15.85</td>
<td>$385.00</td>
<td>$95.1K</td>
<td>205</td>
<td align="right">62</td>
</tr>
<tr>
<td>ADBE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$10.7</td>
<td>$10.6</td>
<td>$10.6</td>
<td>$400.00</td>
<td>$84.8K</td>
<td>4.7K</td>
<td align="right">226</td>
</tr>
<tr>
<td>ADBE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$24.55</td>
<td>$23.2</td>
<td>$23.77</td>
<td>$405.00</td>
<td>$83.1K</td>
<td>492</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Adobe</h3>
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
<h3>Present Market Standing of Adobe</h3>
<ul>
<li>Currently trading with a volume of 1,352,744, the ADBE's price is down by -1.55%, now at $365.67. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 62 days.</li>
</ul>
<h3>Professional Analyst Ratings for Adobe</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $489.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Adobe, targeting a price of $500. 
&#x2A; An analyst from DA Davidson persists with their Buy rating on Adobe, maintaining a target price of $500. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Adobe, which currently sits at a price target of $470. 
&#x2A; An analyst from DA Davidson has decided to maintain their Buy rating on Adobe, which currently sits at a price target of $500. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Adobe with a target price of $475. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Adobe options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

ADBE

Adobe Unusual Options Activity For July 11

Investors with a lot of money to spend have taken a bearish stance on Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with XOM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 17 uncommon options trades for Exxon Mobil.
This isn't normal.
The overall sentiment of these big-money traders is split between 47% bullish and 52%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $83,750, and 14 are calls, for a total amount of $1,791,596.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $85.0 to $125.0 for Exxon Mobil over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Exxon Mobil options trades today is 7282.0 with a total volume of 12,908.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Exxon Mobil's big money trades within a strike price range of $85.0 to $125.0 over the last 30 days.
<h3>Exxon Mobil Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752253242_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/18/26</td>
<td>$9.5</td>
<td>$8.95</td>
<td>$9.05</td>
<td>$120.00</td>
<td>$362.0K</td>
<td>145</td>
<td>1.4K</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/18/26</td>
<td>$9.15</td>
<td>$9.0</td>
<td>$9.02</td>
<td>$120.00</td>
<td>$360.2K</td>
<td>145</td>
<td>738</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$9.2</td>
<td>$8.5</td>
<td>$9.0</td>
<td>$120.00</td>
<td>$360.0K</td>
<td>145</td>
<td>601</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$9.5</td>
<td>$9.0</td>
<td>$9.0</td>
<td>$120.00</td>
<td>$180.0K</td>
<td>145</td>
<td>200</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$1.19</td>
<td>$1.17</td>
<td>$1.18</td>
<td>$125.00</td>
<td>$106.0K</td>
<td>12.2K</td>
<td>948</td>
</tr>
</tbody>
</table>

<h3>About Exxon Mobil</h3>
ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil worldwide. In 2023, it produced 2.4 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At the end of 2023, reserves were 16.9 billion barrels of oil equivalent, 66% of which were liquids. The company is one of the world's largest refiners, with a total global refining capacity of 4.5 million barrels of oil per day, and is one of the world's largest manufacturers of commodity and specialty chemicals.
Following our analysis of the options activities associated with Exxon Mobil, we pivot to a closer look at the company's own performance.
<h3>Exxon Mobil's Current Market Status</h3>
<ul>
<li>With a volume of 4,289,978, the price of XOM is up 0.44% at $115.44. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 21 days.</li>
</ul>
<h3>Expert Opinions on Exxon Mobil</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $129.25.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Exxon Mobil, targeting a price of $127. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Exxon Mobil, targeting a price of $134. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Exxon Mobil with a target price of $131. 
&#x2A; Consistent in their evaluation, an analyst from Scotiabank keeps a Sector Outperform rating on Exxon Mobil with a target price of $125. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Exxon Mobil with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Smart Money Is Betting Big In XOM Options

Investors with a lot of money to spend have taken a bearish stance on Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ISRG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 13 uncommon options trades for Intuitive Surgical.
This isn't normal.
The overall sentiment of these big-money traders is split between 30% bullish and 53%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $264,370, and 6 are calls, for a total amount of $503,844.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $380.0 to $550.0 for Intuitive Surgical during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale activity within a strike price range from $380.0 to $550.0 in the last 30 days. 
<h3>Intuitive Surgical Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752253237_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$156.7</td>
<td>$153.8</td>
<td>$153.8</td>
<td>$420.00</td>
<td>$230.7K</td>
<td align="right">4</td>
<td align="right">15</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$16.2</td>
<td>$15.6</td>
<td>$15.6</td>
<td>$535.00</td>
<td>$65.5K</td>
<td align="right">41</td>
<td align="right">42</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$23.0</td>
<td>$22.9</td>
<td>$22.9</td>
<td>$465.00</td>
<td>$64.1K</td>
<td align="right">115</td>
<td align="right">29</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$146.1</td>
<td>$146.1</td>
<td>$146.1</td>
<td>$400.00</td>
<td>$58.4K</td>
<td align="right">204</td>
<td align="right">4</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$14.1</td>
<td>$13.6</td>
<td>$13.74</td>
<td>$540.00</td>
<td>$56.3K</td>
<td align="right">139</td>
<td align="right">46</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Intuitive Surgical's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 975,331, the ISRG's price is down by -2.83%, now at $511.16. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 11 days.</li>
</ul>
<h3>What The Experts Say On Intuitive Surgical</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $550.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Evercore ISI Group persists with their In-Line rating on Intuitive Surgical, maintaining a target price of $550. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuitive Surgical with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

ISRG

Intuitive Surgical Options Trading: A Deep Dive into Market Sentiment

Domino's Pizza's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) short percent of float has risen 4.02% since its last report. The company recently reported that it has 1.65 million shares sold short, which is 5.44% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.6 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Domino's Pizza Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752253230_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Domino's Pizza has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Domino's Pizza's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Domino's Pizza's peer group average for short interest as a percentage of float is 10.18%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Domino's Pizza's Recent Short Interest

WeRide's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NYSE">WRD</a>) short percent of float has risen 36.32% since its last report. The company recently reported that it has 9.12 million shares sold short, which is 5.18% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.06 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>WeRide Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752253226_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for WeRide has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing WeRide's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, WeRide's peer group average for short interest as a percentage of float is 9.39%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About WeRide?

Coherent's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) short percent of float has risen 13.39% since its last report. The company recently reported that it has 8.29 million shares sold short, which is 6.52% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.38 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Coherent Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752253221_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Coherent has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Coherent's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Coherent's peer group average for short interest as a percentage of float is 3.50%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

COHR

What's Driving the Market Sentiment Around Coherent?

WIIM

Federal Signal shares are trading lower after KeyBanc downgraded the stock from Overweight to Sector Weight.

U.S. oil major Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) has seen its stock rise nearly 7% over the past month, fueled by a dual strategy of cost reduction and strategic investments in both traditional hydrocarbons and future-facing energy.
The company plans a $5 billion blue hydrogen and ammonia facility, &#8220;Project Labrador,&#8221; in Port Arthur, Texas, aiming for a 2027 groundbreaking and 2032 operation.
This project seeks funding through Texas&#8217; HyVelocity Hub and is strategically <a target="_blank" href="https://www.upstreamonline.com/hydrogen/chevron-plans-5-billion-blue-ammonia-plant-as-part-of-texas-hydrogen-hub/2-1-1844733" rel="noreferrer noopener">timed to qualify</a> for the lucrative 45V clean hydrogen production tax credit of up to $3 per kilogram, provided construction begins before January 1, 2028.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46353438/chevron-hess-arbitration-nears-verdict-as-analyst-sees-limited-downside-big-upside-potential" rel="noreferrer noopener">Chevron-Hess Arbitration Nears Verdict As Analyst Sees Limited Downside, Big Upside Potential</a>
Simultaneously, Chevron is undergoing a significant restructuring to enhance efficiency and cut costs. This includes consolidating its offshore operations under a single global division, with centralized functions like HR, IT, and finance managed from hubs in the Philippines and Argentina. Vice Chairman Mark Nelson <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-07-09/chevron-shifts-from-regional-to-centralized-hubs-in-cost-cutting" rel="noreferrer noopener">told</a> Bloomberg this move aims to eliminate organizational complexity and accelerate execution.
This internal overhaul follows a February announcement to cut 20% of the global workforce and reduce expenses by $3 billion. While it coincides with Chevron&#8217;s pending <a target="_blank" href="https://www.benzinga.com/government/24/09/41098199/ftc-clears-chevrons-53b-hess-merger-sets-restriction-for-john-hess" rel="noreferrer noopener">$53 billion acquisition</a> of Hess Corp., this broader push toward operational streamlining appears to be a strategic response to investor pressure for stronger returns, especially amidst ongoing oil price swings and uncertainty over fossil fuel demand.
Despite forecasts of peak oil demand before 2030, Chevron remains committed to traditional exploration and production. It has <a target="_blank" href="https://oilprice.com/Energy/Energy-General/Chevron-Cuts-Layers-Eyes-Guyana-and-Growth.html" rel="noreferrer noopener">launched</a> drilling operations in Namibia, is expanding in Nigeria and Angola, and recently secured rights to explore nine offshore blocks in Brazil&#8217;s Foz do Amazonas basin. Its pursuit of Hess, Exxon&#8217;s partner in the prolific Guyana offshore Stabroek Block, further signals a bullish stance on the long-term value of hydrocarbons.
Chevron is also expanding its global presence through a $34 billion memorandum of understanding between U.S. and Indonesian entities. Reuters noted that the agreement, signed July 7, includes Chevron, Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), and Indonesia&#8217;s state-owned Pertamina. It covers broad energy and agricultural trade, including large purchases of U.S. crops like soybeans, corn, and cotton.
In an industry shaped by volatility, Chevron&#8217;s strategy reflects a dual-track approach: cutting costs while deepening investments across fossil fuels and future-facing energy projects.
Price Action: CVX stock is trading higher by 0.38% to $154.76 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/upgrades/25/07/46368617/federal-signals-deliberate-strategic-decisions-could-sideline-smaller-competitors" target="_blank" rel="noreferrer noopener">Federal Signal&#8217;s &#8216;Deliberate Strategic Decisions&#8217; Could Sideline Smaller Competitors</a></li>
</ul>
Photo via Shutterstock

Large Cap

Chevron's Cost Cuts, Diversified Growth Propel Stock

<a href="https://www.bloomberg.com/news/articles/2025-07-11/eu-edges-closer-to-new-price-cap-regime-for-russian-oil-trade?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-11/eu-edges-closer-to-new-price-cap-regime-for-russian-oil-trade?embedded-checkout=true</a>

'EU Edges Closer to New Price-Cap Regime for Russian Oil Trade'- Bloomberg

MongoDB Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) is currently in Phase 10 of its 18-phase Adhishthana Cycle on the weekly chart. After peaking in November 2021, the stock has struggled to regain momentum, now down over 65% from its all-time highs in 2021, and showing no signs of a recovery. Let's explore what led to this correction and why Adhishthana Principles suggest it may persist for years.
<h3 class="wp-block-heading">What Went Wrong with MongoDB&#8217;s Cycle?</h3>
Under the Adhishthana framework, stocks form a structure known as the Adhishthana Cakra between Phases 4 to 8. This is typically a channel or arc pattern, from which a breakout in Phase 9 signals the beginning of a strong bullish move.
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="1200" height="441" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/11053943/MongoDB-Cakra-Adhishthana-.png" alt="Fig.1 MongoDB Weekly Cakra Breakdown (Source: Adhishthana.com Reports)" class="wp-image-15653" style="width:624px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/11053943/MongoDB-Cakra-Adhishthana-.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/11053943/MongoDB-Cakra-Adhishthana--300x110.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/11053943/MongoDB-Cakra-Adhishthana--1024x376.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/11053943/MongoDB-Cakra-Adhishthana--768x282.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /><figcaption class="wp-element-caption">Fig.1 MongoDB Weekly Cakra Breakdown (Source: Adhishthana.com Reports)</figcaption></figure>
MongoDB did follow this structure initially, forming a textbook Cakra and respecting the lower arc during its build-up. However, instead of breaking out to the upside in Phase 9, the stock broke down.
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">"When the underlying breaks the Cākra on the flip side, it typically draws consolidation up to the Guna triads. The movement after the break is typically highly significant, and the selling momentum is extremely strong. Such a move shall be called the Move of Pralayā." — Adhishthana: The Principles That Govern Wealth, Time &amp; Tragedy
</blockquote>
This breakdown marked the start of a bearish stretch. The principles suggest that after a Move of Pralaya, a meaningful recovery is unlikely before the stock completes Phase 13. MongoDB is currently in Phase 10, and Phase 13 is set to conclude by October 24, 2027.
<h3 class="wp-block-heading">Monthly Chart Adds to the Weakness</h3>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="1200" height="516" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/11054329/MongoDB-Monthly-Adhishthana-.png" alt="Fig.2 MongoDB Monthly Chart (Source: Adhishthana.com Reports) " class="wp-image-15654" style="width:675px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/11054329/MongoDB-Monthly-Adhishthana-.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/11054329/MongoDB-Monthly-Adhishthana--300x129.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/11054329/MongoDB-Monthly-Adhishthana--1024x440.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/11054329/MongoDB-Monthly-Adhishthana--768x330.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /><figcaption class="wp-element-caption">Fig.2 MongoDB Monthly Chart (Source: Adhishthana.com Reports) </figcaption></figure>
On the monthly chart, MongoDB is in its second half of Phase 2, known as the Buddhi Move zone. But since the Sankhya Period (the early segment of Phase 2) wasn't structurally sound according to the principles, the likelihood of a sustained rally from this point is low.
<h3 class="wp-block-heading">Investor Outlook: Time to Stay Away</h3>
Given the long consolidation ahead and lack of structural strength, MongoDB is not a favorable pick for now. Existing shareholders may consider credit spread strategies to hedge against continued downside and slumps.
For new investors, it may be wise to stay on the sidelines until Phase 13 is complete and a structural shift is visible. The stock might rally at times, but it would be wise to avoid chasing those.&nbsp;
The breakdown of the Cakra has triggered the Move of Pralaya, and historical data under the Adhishthana model shows that recoveries during this phase window are not sustainable. Until then, caution is key.

Technicals

Opinion

Signals

MongoDB Stock: Weak Structure Suggests Prolonged Slump

<a href="https://www.bloomberg.com/news/articles/2025-07-11/rio-tinto-wants-to-invest-more-in-us-copper-under-trump-tariffs?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-11/rio-tinto-wants-to-invest-more-in-us-copper-under-trump-tariffs?embedded-checkout=true</a>

'Rio Tinto Wants to Invest More in US Copper Under Trump Tariffs'- Bloomberg

Former Speaker of the House Nancy Pelosi recently <a href="http://Read Next: •	Top 10 Stock Traders In Congress For 2024: How Nancy Pelosi, Pete Sessions, Susan Collins, Marjorie Taylor Greene Rank">disclosed a new tech stock purchase</a> and the buy was made at a huge discount to what retail investors have been paying. Here's how.
What Happened: Similar to a <a href="https://www.benzinga.com/news/education/25/07/46356805/nancy-pelosis-nvidia-stake-heres-how-much-former-speaker-is-up-on-options-bought-in-2023">huge stake in</a> NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Nancy Pelosi and her husband Paul Pelosi now have a sizable stock stake in Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>).
Broadcom Inc. is one of the largest semiconductor companies in the world, and like Nvidia, is benefiting from the surge in demand for AI chips and networking solutions.
Pelosi's latest disclosure shows that her husband exercised 200 call options for 20,000 Broadcom shares on June 20 with a strike price of $80.
The options had an expiration date of Jun 20, 2025 and were originally purchased by the Pelosis back on June 24, 2024.
Based on a current share price of $273.15, the Pelosis just bought their Broadcom stock at a 71% discount to the market value with the $80 strike price. The Pelosis received a discount of approximately 68% on June 20 when exercising the options.
Pelosi previously disclosed buying 20 call options with an $800 strike price and June 20, 2025 expiration in June 2024. A ten-for-one stock split changed the number of options and strike price.
Along with disclosing the Broadcom trade, the Pelosis also disclosed a rare losing trade. The filing said the Pelosis sold 2,822 units of the Matthews International Fund. The comments section stated that the sale was conducted at a loss of $28,948. The sale could have been done for tax purposes to offset capital gains.
Did You Know?
<ul class="wp-block-list">
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent071125">Get Tips On What They Bought And Sold With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: The latest Broadcom stock purchase highlights <a href="https://www.benzinga.com/general/entertainment/22/03/26065543/the-pelosi-options-trading-strategy-3-key-takeaways">a common practice </a>by Paul Pelosi. The venture capitalist likes to buy call options in large-cap technology stocks.
The options bought are typically in-the-money LEAPS, which means the strike price is below the current market price and have an expiration date of more than one year from the current date.
Past disclosures have shown that the Pelosis typically hold the call options until the expiration date when a decision is made to either sell the options or exercise the options and buy a stock stake at the strike price.
With the latest disclosure, Broadcom has now become a top holding for the Pelosis alongside Nvidia.
Nancy Pelosi says she does not share information on congressional activities with her husband. Observers remain skeptical, given the&nbsp;<a href="https://www.benzinga.com/markets/equities/24/01/36768614/tech-giants-nvidia-amd-ibm-microsoft-google-partner-with-us-government-for-ai-research-project" target="_blank" rel="noreferrer noopener">questionable timing</a>&nbsp;of her disclosed trades.
Pelosi&#8217;s annual salary falls between $174,000 and $197,000 as a senior member of Congress. When she served as Speaker of the House, her annual salary was $223,500.
An&nbsp;<a href="https://www.benzinga.com/markets/penny-stocks/23/02/30768851/want-to-copy-master-trader-nancy-pelosis-investments-theres-an-etf-for-that-here-are-the-hol" target="_blank" rel="noreferrer noopener">ETF to track</a>&nbsp;the stock trading activity of Democrats in Congress, the&nbsp;Unusual Whales Subversive Democratic Trading ETF&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/NANC#BATS">NANC</a>),&nbsp;bears the Representative&#8217;s name in the stock ticker.
Increased calls to ban Congress members and their spouses from trading have also centered on Pelosi, a Democrat. One bill even uses her name as an acronym:<a href="https://www.benzinga.com/politics/25/04/45077654/bill-named-after-nancy-pelosi-could-ban-congress-members-from-trading-stocks-what-you-need-to-know-about-the-pelosi-act" target="_blank" rel="noreferrer noopener">&nbsp;the PELOSI Act.</a>
 Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/01/42860759/10-best-stock-traders-in-congress-in-2024-where-do-nancy-pelosi-pete-sessions-susan-collins-marjorie-taylor-greene-rank" target="_blank" rel="noreferrer noopener">Top 10 Stock Traders In Congress For 2024: How Nancy Pelosi, Pete Sessions, Susan Collins, Marjorie Taylor Greene Rank</a></li>
</ul>
Photo: Asatur Yesayants/Shutterstock

Politics

Tech

AVGO

NANC

NVDA

Nancy Pelosi Just Bought Tech Stock At 71% Discount To Current Price—Here's How

Health Care

Press Releases

Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study

Earnings

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

Mainz Biomed Enters into Technology Partnership with EDX Medical Group

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study

Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

Financing

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

MYNZ

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

AIM ImmunoTech

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

Aprea Therapeutics

Aptevo Therapeutics

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

Cardio Diagnostics Holdings Inc. - Common stock

Cardio Diagnostics Hldgs

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Genprex

GT Biopharma

HCW Biologics

Immuron Limited - American Depositary Shares

Immuron

IN8bio

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

Moleculin Biotech

PharmaCyte Biotech

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Sunshine Biopharma

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Tharimmune

Turnstone Biologics

Maxim Group

JonesTrading

Screenshot 2025-04-15 at 7.03.21 PM

Biotech

Mainz Biomed Narrows Its Losses, Grows Revenue For Full Year 2024

Screenshot 2025-04-02 at 9.29.30 PM

Mainz BioMed&#39;s Trial To Bring Critical Early Cancer Detection One Step Closer

Screenshot 2024-12-19 at 7.13.05 PM

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

Screenshot 2024-11-21 at 6.41.48 PM

Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test

Screenshot 2024-11-12 at 8.43.58 PM

Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening

Screenshot 2024-11-11 at 7.48.49 PM

What Mainz Biomed (NASDAQ: MYNZ) Has Been Up To Recently And Why Frankie Muniz Is A Backer

Screenshot 2024-10-04 at 11.57.48 PM

Interview

Former Senior Advisor To Obama Joins Forces With Innovative Biotech To Catch Cancer Early

Screenshot 2024-09-04 at 5.52.15 PM

Mainz Biomed (NASDAQ: MYNZ) And Liquid Biosciences Team Up To Fight Pancreatic Cancer With Early Detection Tool

Screenshot 2024-08-30 at 2.55.26 PM

Emerging Markets

Early Cancer Detection Saves Lives - This Biotech Has A Promising New Test

Screenshot 2024-08-30 at 6.27.59 PM

EXAS

Mainz Biomed Seeks FDA Approval For Colorectal Cancer Test It Says Is Nearly Twice As Sensitive As Others – A Look At Pipeline And Milestones

Comments

Mainz Biomed

Notizie

Ultime notizie per Mainz Biomed (NASDAQ:MYNZ) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO